The effects of dietary selenomethionine on polyamines and azoxymethane-induced aberrant crypts

被引:24
作者
Baines, AT
Holubec, H
Basye, JL
Thorne, P
Bhattacharyya, AK
Spallholz, J
Shriver, B
Cui, HY
Roe, D
Clark, LC
Earnest, DL
Nelson, MA
机构
[1] Univ Arizona, Arizona Canc Ctr, Mol Oncol Lab, Tucson, AZ 85724 USA
[2] Univ Arizona, Dept Pharmacol Toxicol, Tucson, AZ 85724 USA
[3] Univ Arizona, Dept Gastroenterol, Tucson, AZ 85724 USA
[4] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA
[5] Texas Tech Univ, Dept Food & Nutr, Lubbock, TX 79409 USA
[6] Univ Arizona, Ctr Epidemiol, Tucson, AZ 85724 USA
关键词
selenomethionine; cancer prevention; abberant crypts;
D O I
10.1016/S0304-3835(00)00585-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We evaluated the effects of dietary selenomethionine supplementation on colonic polyamine levels and the ability of L-selenomethionine supplementation to modulate the carcinogenic activity of azoxymethane (AOM) in the rat colon, Four-week-old male F344 rats were treated with 15 mg/kg body weight of AOM once a week for 2 weeks. Dietary selenomethionine at a concentration of either I or ? ppm was administered in AIN-76A rodent diet to AOM-treated animals for 16 weeks. Aberrant crypt foci (ACF), precursor lesions of colon cancer, were investigated after the 16 week treatment course. Selenomethionine given in the diet at 2 ppm markedly reduced the number of aberrant crypt foci. The multiplicity of ACFs (i.e. the number of aberrant crypts/focus) anti the percentage of microadenomas were also affected by selenomethionine in a dose dependent manner. However, evaluation of the colonic tissue polyamine levels between control and treated groups showed no significant difference.. These results demonstrate that selenomethionine can modulate the development of AOM-induced premalignant lesions through a polyamine-independent mechanism. (C) 2000 Elsevier Science lreland Ltd. All rights reserved.
引用
收藏
页码:193 / 198
页数:6
相关论文
共 19 条
[1]   ROLE OF ABERRANT CRYPT FOCI IN UNDERSTANDING THE PATHOGENESIS OF COLON-CANCER [J].
BIRD, RP .
CANCER LETTERS, 1995, 93 (01) :55-71
[2]   Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin a randomized controlled trial - A randomized controlled trial [J].
Clark, LC ;
Combs, GF ;
Turnbull, BW ;
Slate, EH ;
Chalker, DK ;
Chow, J ;
Davis, LS ;
Glover, RA ;
Graham, GF ;
Gross, EG ;
Krongrad, A ;
Lesher, JL ;
Park, HK ;
Sanders, BB ;
Smith, CL ;
Taylor, JR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (24) :1957-1963
[3]  
CLARK LC, 1985, FED PROC, V44, P2584
[4]   Dietary selenium reduces the formation of aberrant crypts in rats administered 3,2′-dimethyl-4-aminobiphenyl [J].
Feng, Y ;
Finley, JW ;
Davis, CD ;
Becker, WK ;
Fretland, AJ ;
Hein, DW .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1999, 157 (01) :36-42
[5]   Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase [J].
Ganther, HE .
CARCINOGENESIS, 1999, 20 (09) :1657-1666
[6]  
GERNER EW, 1994, CANCER EPIDEM BIOMAR, V3, P325
[7]  
Losi L, 1996, J PATHOL, V178, P259
[8]  
MAGNUSON BA, 1993, CANCER RES, V53, P4499
[9]   SELENIUM AND DIFLUOROMETHYLORNITHINE ADDITIVELY INHIBIT DMH-INDUCED DISTAL COLON-TUMOR FORMATION IN RATS FED A FIBER-FREE DIET [J].
MCGARRITY, TJ ;
PEIFFER, LP .
CARCINOGENESIS, 1993, 14 (11) :2335-2340
[10]   DOSE-RESPONSE AND PROLIFERATIVE CHARACTERISTICS OF ABERRANT CRYPT FOCI - PUTATIVE PRENEOPLASTIC LESIONS IN RAT COLON [J].
MCLELLAN, EA ;
MEDLINE, A ;
BIRD, RP .
CARCINOGENESIS, 1991, 12 (11) :2093-2098